INVESTER I GENETIX BIOTHERAPEUTICS MED ENDAVU: Køb Genetix Biotherapeutics ($BLUE) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Genetix Biotherapeutics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Bluebird Bio Inc. is a biotechnology company that focuses on developing innovative gene therapies for severe genetic diseases and cancer. The company's primary purpose is to harness the power of gene-editing technologies to create transformational therapies that can potentially cure life-threatening conditions. Bluebird Bio's product pipeline includes treatments for conditions such as sickle cell disease, beta-thalassemia, and certain types of cancer, emphasizing its impact on the healthcare industry. By using cutting-edge methodologies like lentiviral-based gene addition and editing, Bluebird Bio aims to address underlying genetic causes of diseases, offering hope for long-lasting solutions where traditional therapies fall short. Founded in 1992 and headquartered in Cambridge, Massachusetts, Bluebird Bio is a significant player in the biotech sector. It contributes to advancements in genomic medicine, helping to pave the way for personalized treatments that could redefine standards of care in the medical field. Its work reflects the growing importance of genetic research and therapy in improving patient outcomes and expanding the possibilities of medical science.